Browsing by Author "Solo, Karla"

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
    (2021) Cuker, Adam; Tseng, Eric K.; Nieuwlaat, Robby; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; Davila, Jennifer; DeSancho, Maria T.; Diuguid, David; Griffin, Daniel O.; Kahn, Susan R.; Klok, Frederikus A.; Lee, Alfred Ian; Neumann, Ignacio; Pai, Ashok; Pai, Menaka; Righini, Marc; Sanfilippo, Kristen M.; Siegal, Deborah; Skara, Mike; Touri, Kamshad; Akl, Elie A.; Akl, Imad Bou; Boulos, Mary; Brignardello-Petersen, Romina; Charide, Rana; Chan, Matthew; Dearness, Karin; Darzi, Andrea J.; Kolb, Philipp; Colunga-Lozano, Luis E.; Mansour, Razan; Morgano, Gian Paolo; Morsi, Rami Z.; Noori, Atefeh; Piggott, Thomas; Qiu, Yuan; Roldan, Yetiani; Schuenemann, Finn; Stevens, Adrienne; Solo, Karla; Ventresca, Matthew; Wiercioch, Wojtek; Mustafa, Reem A.; Schuenemann, Holger J.
    Background: Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).
  • No Thumbnail Available
    Item
    American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
    (2022) Cuker, Adam; Tseng, Eric K.; Nieuwlaat, Robby; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; DeSancho, Maria T.; Diuguid, David; Griffin, Daniel O.; Kahn, Susan R.; Klok, Frederikus A.; Lee, Alfred Ian; Neumann, Ignacio; Pai, Ashok; Righini, Marc; Sanfilippo, Kristen M.; Siegal, Deborah M.; Skara, Mike; Terrell, Deirdra R.; Touri, Kamshad; Akl, Elie A.; Al Jabiri, Reyad; Al Jabiri, Yazan; Barbara, Angela M.; Bognanni, Antonio; Boulos, Mary; Brignardello-Petersen, Romina; Charide, Rana; Colunga-Lozano, Luis E.; Dearness, Karin; Darzi, Andrea J.; Hussein, Heba; Karam, Samer G.; Mansour, Razan; Morgano, Gian Paolo; Morsi, Rami Z.; Muti-Schunemann, Giovanna; Nadim, Menatalla K.; Philip, Binu A.; Qiu, Yuan; Benitez, Yetiani Roldan; Stevens, Adrienne; Solo, Karla; Wiercioch, Wojtek; Mustafa, Reem A.; Schuenemann, Holger J.
    Background: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE).
  • No Thumbnail Available
    Item
    American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
    (2022) Cuker, Adam; Tseng, Eric K.; Nieuwlaat, Robby; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; Davila, Jennifer; DeSancho, Maria T.; Diuguid, David; Griffin, Daniel O.; Kahn, Susan R.; Klok, Frederikus A.; Lee, Alfred Ian; Neumann, Ignacio; Pai, Ashok; Righini, Marc; Sanfilippo, Kristen M.; Siegal, Deborah; Skara, Mike; Terrell, Deirdra R.; Touri, Kamshad; Akl, Elie A.; Al Jabiri, Reyad Nayif; Al Jabiri, Yazan Nayif; Barbara, Angela M.; Bognanni, Antonio; Akl, Imad Bou; Boulos, Mary; Brignardello-Petersen, Romina; Charide, Rana; Chan, Matthew; Colunga-Lozano, Luis E.; Dearness, Karin; Darzi, Andrea J.; Hussein, Heba; Karam, Samer G.; Kolb, Philipp; Mansour, Razan; Morgano, Gian Paolo; Morsi, Rami Z.; Muti-Schunemann, Giovanna; Nadim, Menatalla K.; Noori, Atefeh; Philip, Binu A.; Piggott, Thomas; Qiu, Yuan; Benitez, Yetiani Roldan; Schunemann, Finn; Stevens, Adrienne; Solo, Karla; Wiercioch, Wojtek; Mustafa, Reem A.; Schunemann, Holger J.
    Background: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE).
  • No Thumbnail Available
    Item
    American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
    (2021) Cuker, Adam; Tseng, Eric K.; Nieuwlaat, Robby; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; Davila, Jennifer; DeSancho, Maria T.; Diuguid, David; Griffin, Daniel O.; Kahn, Susan R.; Klok, Frederikus A.; Lee, Alfred Ian; Neumann, Ignacio; Pai, Ashok; Righini, Marc; Sanfilippo, Kristen M.; Siegal, Deborah; Skara, Mike; Terrell, Deirdra R.; Touri, Kamshad; Akl, Elie A.; Akl, Imad Bou; Bognanni, Antonio; Boulos, Mary; Brignardello-Petersen, Romina; Charide, Rana; Chan, Matthew; Dearness, Karin; Darzi, Andrea J.; Kolb, Philipp; Colunga-Lozano, Luis E.; Mansour, Razan; Morgano, Gian Paolo; Morsi, Rami Z.; Muti-Schunemann, Giovanna; Noori, Atefeh; Philip, Binu A.; Piggott, Thomas; Qiu, Yuan; Roldan, Yetiani; Schuenemann, Finn; Stevens, Adrienne; Solo, Karla; Wiercioch, Wojtek; Mustafa, Reem A.; Schuenemann, Holger J.
    Background: COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19-related critical illness who do not have confirmed or suspected VTE.
  • No Thumbnail Available
    Item
    Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study
    (2023) Dewidar, Omar; Bondok, Mostafa; Abdelrazeq, Leenah; Aliyeva, Khadija; Solo, Karla; Welch, Vivian; Brignardello-Petersen, Romina; Mathew, Joseph L.; Hazlewood, Glen; Pottie, Kevin; Hartling, Lisa; Khalifa, Dina Sami; Duda, Stephanie; Falavigna, Maicon; Khabsa, Joanne; Lotfi, Tamara; Petkovic, Jennifer; Elliot, Sarah; Chi, Yuan; Parker, Roses; Kristjansson, Elizabeth; Riddle, Alison; Darzi, Andrea J.; Magwood, Olivia; Saad, Ammar; Radav, Gabriel; Neumann, Ignacio; Loeb, Mark; Reveiz, Ludovic; Mertz, Dominik; Piggott, Thomas; Turgeon, Alexis F.; Schunemann, Holger; Tugwell, Peter
    Background and Objective: To identify COVID-19 actionable statements (e.g., recommendations) focused on specific disadvantaged populations in the living map of COVID-19 recommendations (eCOVIDRecMap) and describe how health equity was assessed in the development of the formal recommendations. Methods: We employed the place of residence, race or ethnicity or culture, occupation, gender or sex, religion, education, socio-economic status, and social capital-Plus framework to identify statements focused on specific disadvantaged populations. We assessed health equity considerations in the evidence to decision frameworks (EtD) of formal recommendations for certainty of evidence and impact on health equity criteria according to the Grading of Recommendations, Assessment, Development, and Evaluations criteria.Results: We identified 16% (124/758) formal recommendations and 24% (186/819) good practice statements (GPS) that were focused on specific disadvantaged populations. Formal recommendations (40%, 50/124) and GPS (25%, 47/186) most frequently focused on children. Seventy-six percent (94/124) of the recommendations were accompanied with EtDs. Over half (55%, 52/94) of those considered indirectness of the evidence for disadvantaged populations. Considerations in impact on health equity criterion most frequently involved implementation of the recommendation for disadvantaged populations (17%, 16/94). Conclusion: Equity issues were rarely explicitly considered in the development COVID-19 formal recommendations focused on specific disadvantaged populations. Guidance is needed to support the consideration of health equity in guideline development during health emergencies.& COPY; 2023 Elsevier Inc. All rights reserved.